PM Group’s Post

Steriline ends 2024 by consolidating its presence in the ophthalmic sector, a market in which Annex 1 has required a significant improvement in technologies. https://lnkd.in/e9bynfWr #pharma #ophthalmic #robotics

Innovating the Cold Chain: Transforming Lives at InnovatorMD World Congress 2024 Thrilled to announce that Steve Scully, MD, PhD, will be presenting Thaddeus Medical Systems, Inc. at the InnovatorMD World Congress 2024! As an M.D./Ph.D. turned entrepreneur, Steve is passionate about leveraging innovation to prevent medical errors, particularly in Clinical Pathology and Pharmacology. At Thaddeus Medical Systems, that passion translates into the Thaddeus Cold Chain System. Our game-changing technology ensures the safe and secure transport of temperature-sensitive medical products, including life-saving vaccines and biologics. This means these critical supplies reach patients around the world without spoilage, guaranteeing their efficacy and ultimately, saving lives. Join Steve at InnovatorMD to learn how Thaddeus Medical Systems is transforming the cold chain, one seamless journey at a time! Uli K. Chettipally, MD., MPH., Paula Muto, MD, Suzy Engwall, Miguel Angel Villagra Diaz MD ADOCTORSJOURNEY, Omar Shaker, MD #InnovatorMD #ColdChain #MedicalInnovation #ThaddeusMedical #Vaccines #SavingLives

Over half of respondents in our recent study on medical imaging considered the Quality/reliability of the readings to be the single most important attribute when selecting a medical imaging service provider. The medical imaging services market is an important part of the biopharmaceutical industry, from research to diagnostics and treatment, playing a key role in clinical trials for novel therapies. Our Medical Imaging Market Dynamics and Service Provider Performance report is designed to: --- 1. Help sponsor organizations and CROs make more informed medical imaging provider selection decisions - Understand how your peers in the industry select medical imaging providers, including critical selection metrics and the use of preferred provider agreements. - Learn how the market perceives the 17 medical imaging providers included in this research: Which providers are considered leaders? Which providers would outsourcers prefer to work with if the decision were entirely up to them? - Evaluate how medical imaging providers have performed for their recent customers to learn which providers might be a good fit for the needs of your trials. --- --- 2. Help medical imaging providers optimize operational and marketing strategies - Discover which medical imaging services are most likely to be outsourced over the next 18 months as well as which imaging modalities are expected to grow in demand to ensure your capabilities and services are aligned with market needs. - Better understand your customers’ buying process including selection metrics and departmental influence when selecting a medical imaging provider. - Gain a better understanding of your brand via data on perceived leadership, awareness, familiarity, and preference for your company and competitors. - Assess how your customers rated your company’s performance to develop messaging around your strengths and improve on perceived weaknesses. --- View report on our research portal: https://lnkd.in/dEkvH9q8 #pharmaceuticals #medicalimaging #clinicaltrials #marketresearch Biospective Inc. / CALYX / Canfield Scientific / Cardialysis / Clario / ICON plc / Imaging Endpoints / Invicro / IXICO / Median Technologies / Medical Metrics, Inc. / Medpace / Philips Pharma Solutions, formerly BioTel Research / Radiantsage / Resonance Health Ltd / WCG / WorldCare Clinical (now Voiant)

Delivering innovative medical devices and combination products for the patients of tomorrow begins with conducting safety and efficacy preclinical medical device testing today. Leverage the 40 years of knowledge our specialists can provide to your program with fast turnaround times. Schedule your required tests now. #MedicalDeviceTesting #Biocompatibility #Microbiology #SterilityValidation #SurgicalTesting

Delivering innovative medical devices and combination products for the patients of tomorrow begins with conducting safety and efficacy preclinical medical device testing today. Leverage the 40 years of knowledge our specialists can provide to your program with fast turnaround times. Schedule your required tests now. #MedicalDeviceTesting #Biocompatibility #Microbiology #SterilityValidation #SurgicalTesting

Discover how data is reshaping the pharmaceutical industry's landscape of personalised patient care. Our blog, 'How Data is Shaping Personalised Patient Care in Pharmaceuticals', explores the critical role of data-driven strategies in enhancing patient-centric innovations. From wearable technology to remote patient monitoring, learn about the advancements that are setting new standards in healthcare. 👉https://lnkd.in/e47rQzf9

Order your 'Global Microchip Drug Delivery Device Market - Forecasts to 2029' FREE Sample Report via https://lnkd.in/dtJUn24f Hello LinkedIn community! Today, let's explore the evolving landscape of microchip drug delivery devices and how the global market is projected to transform by 2029. This technology represents a groundbreaking approach to personalized medicine and enhanced patient care. Microchip drug delivery devices, often referred to as "smart implants," are miniature devices embedded with microchips that can precisely control the release of medications within the body. These devices offer several advantages, including targeted drug delivery, reduced side effects, and improved patient adherence to treatment regimens. So, how is the global market for microchip drug delivery devices expected to evolve over the next decade? Increased Adoption: By 2029, we anticipate a significant increase in the adoption of microchip drug delivery devices across various therapeutic areas. From chronic diseases like diabetes and cardiovascular conditions to neurodegenerative disorders and cancer, these devices will offer tailored solutions to address specific patient needs. Technological Advancements: Rapid advancements in microchip technology, including miniaturization, improved biocompatibility, and enhanced wireless communication capabilities, will drive innovation in drug delivery systems. This will enable more precise and programmable administration of medications, optimizing therapeutic outcomes. Expansion in Applications: The scope of applications for microchip drug delivery devices will broaden. Beyond traditional implants, we'll see advancements in ingestible microchips for oral drug delivery, wearable devices for continuous monitoring and delivery, and even injectable microchips for targeted treatments. Shift Towards Personalized Medicine: With the ability to tailor drug release profiles based on individual patient characteristics, microchip drug delivery devices will facilitate the shift towards personalized medicine. This approach ensures optimal efficacy and safety while minimizing unnecessary exposure to medications. Reflecting on my experience in healthcare innovation, I've witnessed the transformative potential of microchip drug delivery devices. Intersect ENT, Inc., Now Part of Medtronic Atossa Therapeutics, Inc. Theradaptive Microchips Inc Innocoll Biotherapeutics Flowonix Medical Nectero Medical, Inc. Regentis Biomaterials Promimic Re-Vana Therapeutics #GlobalMicrochipDrugDeliveryDeviceMarket #GlobalMarketEstimates #GME #DrugDelivery #HealthcareInnovation #MicrochipTechnology #PersonalizedMedicine #DigitalHealth #FutureOfHealthcare #MedicalDevices #PatientCare #TherapeuticInnovation #HealthTech

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #MedicalDevices #Chromatography #Biopharmaceuticals #SingleUseSystems #VirusPurification #TherapeuticProteins #DNApurification #MarketGrowth #HealthcareInnovation #GlobalMarket

Delivering innovative medical devices and combination products for the patients of tomorrow begins with conducting safety and efficacy preclinical medical device testing today. Leverage the 40 years of knowledge our specialists can provide to your program with fast turnaround times. Schedule your required tests now. #MedicalDeviceTesting #Biocompatibility #Microbiology #SterilityValidation #SurgicalTesting

Delivering innovative medical devices and combination products for the patients of tomorrow begins with conducting safety and efficacy preclinical medical device testing today. Leverage the 40 years of knowledge our specialists can provide to your program with fast turnaround times. Schedule your required tests now. #MedicalDeviceTesting #Biocompatibility #Microbiology #SterilityValidation #SurgicalTesting